REFERENCES
- Kaiser PK, Do DV. Ranibizumab for the treatment of neovascular AMD. Int J Clin Pract. 2007;61:501–509.
- Perrin RM, Konopatskaya O, Qiu Y, et al. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia. 2005;48:2422–2427.
- Ng YS, Krilleke D, Shima DT. VEGF function in vascular pathogenesis. Exp Cell Res. 2006;312:527–537.
- Bates DO, Cui TG, Doughty JM, et al. VEGF(165)b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 2002;62:4123–4131.
- Zhang B, Hu Y, Ma JX. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Invest Ophth Vis Sci. 2009;50:3943–3952.
- Woolard J, Nowak D, Ladomery M, et al. Splice factor regulation of alternative splicing of VEGF isoform families. Faseb J. 2006;20:A539–A539.
- Caceres J, Kornblihtt A. Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet. 2002;18:186–193.
- Screaton GR, Caceres JF, Mayeda A, et al. Identification and characterization of 3 members of the human SR family of pre-messenger-RNA splicing factors. Embo J. 1995;14:4336–4349.
- Caceres JF, Krainer AR. Functional-analysis of premessenger RNA splicing factor SF2/ASF structural domains. Embo J. 1993;12:4715–4726.
- Caceres JF, Misteli T, Screaton GR, et al. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol. 1997;138:225–238.
- Peng XB, Mount SM. Genetic enhancement of RNA-processing defects by a dominant mutation in B52, the drosophila gene for an SR protein splicing factor. Mol Cell Biol. 1995;15:6273–6282.
- Chiu YL, Pin OY. Loss of PNN expression attenuates expression levels of SR family splicing factors and modulates alternative pre-mRNA splicing in vivo. Biochem Bioph Res Co. 2006;341:663–671.
- Watson CJ, Webb NJA, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine. 2000;12:1232–1235.
- Powell B, Toomes C, Scott S, et al. Polymorphisms in OPA1 are associated with normal tension glaucoma. Mol Vis. 2003;9:460–464.
- Churchill AJ, Carter JG, Lovell HC, et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet. 2006;15:2955–2961.
- Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73:1162–1169.
- Heinemeyer T, Wingender E, Reuter I, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl Acids Res. 1998;26:362–367.